-
Loading metrics
A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia
- Carmen D. Schweighofer,
- Kevin R. Coombes,
- Lynn L. Barron,
- Lixia Diao,
- Rachel J. Newman,
- Alessandra Ferrajoli,
- Susan O'Brien,
- William G. Wierda,
- Rajyalakshmi Luthra,
- L. Jeffrey Medeiros
x
- Published: December 14, 2011
- https://doi.org/10.1371/journal.pone.0028277
Viewed
Cited
Discussed
Powered by Altmetric
Questions or concerns about usage data? Please let us know.
Saved